title: Primary human chondrocyte extracellular matrix formation and phenotype maintenance using RGD-derivatized PEGDM hydrogels possessing a continuous Young's modulus gradient.
abstract: Efficient ex vivo methods for expanding primary human chondrocytes while maintaining the phenotype is critical to advancing the sourcing of autologous cells for tissue engineering applications. While there has been significant research reported in the literature, systematic approaches are necessary to determine and optimize the chemical and mechanical scaffold properties for hyaline cartilage generation using limited cell numbers. Functionalized hydrogels possessing continuous variations in physico-chemical properties are, therefore, an efficient three-dimensional platform for studying several properties simultaneously. Herein we describe a polyethylene glycol dimethacrylate (PEGDM) hydrogel system with a modulus gradient (~27,000-3800 Pa) containing a uniform concentration of arginine-glycine-aspartic acid (RGD) peptide to enhance cell adhesion in order to correlate primary human osteoarthritic chondrocyte proliferation, phenotype maintenance, and extracellular matrix (ECM) production with hydrogel properties. Cell number and chondrogenic phenotype (CD14:CD90 ratios) were found to decline in regions with a higher storage modulus (>13,100 Pa), while regions with a lower storage modulus maintained their cell number and phenotype. Over 3 weeks culture hydrogel regions possessing a lower Young's modulus experienced an increase in ECM content (~200%) compared with regions with a higher storage modulus. Variations in the amount and organization of the cytoskeletal markers actin and vinculin were observed within the modulus gradient, which are indicative of differences in chondrogenic phenotype maintenance and ECM expression. Thus scaffold mechanical properties have a significant impact in modulating human osteoarthritic chondrocyte behavior and tissue formation.
authors.affiliation: Department of Polymer Science, The University of Akron, Akron, OH 44325-3909, USA.
authors.forename: Laura A Smith
authors.initials: LA
authors.lastname: Callahan
authors.forename: Anna M
authors.initials: AM
authors.lastname: Ganios
authors.forename: Erin P
authors.initials: EP
authors.lastname: Childers
authors.forename: Scott D
authors.initials: SD
authors.lastname: Weiner
authors.forename: Matthew L
authors.initials: ML
authors.lastname: Becker
mesh_terms: D001672:Biocompatible Materials / Q000138:chemical synthesis; D002478:Cells, Cultured; D019902:Chondrocytes / Q000166:cytology / Q000502:physiology*; D019245:Compressive Strength; D055119:Elastic Modulus; D004867:Equipment Design; D019544:Equipment Failure Analysis; D005109:Extracellular Matrix / Q000378:metabolism*; D006801:Humans; D020100:Hydrogels / Q000737:chemistry; D008422:Materials Testing; D040542:Mechanotransduction, Cellular / Q000502:physiology*; D008689:Methacrylates / Q000138:chemical synthesis*; D009842:Oligopeptides / Q000737:chemistry*; D011092:Polyethylene Glycols / Q000138:chemical synthesis*; D023822:Tissue Engineering / Q000295:instrumentation*; D054457:Tissue Scaffolds
chemical_list: D001672:Biocompatible Materials; D020100:Hydrogels; D008689:Methacrylates; D009842:Oligopeptides; C421283:poly(ethylene glycol)-dimethacrylate; D011092:Polyethylene Glycols; C047981:arginyl-glycyl-aspartic acid